Balaji Telefilms holds 32nd AGM, clarifies compliance delays
- Balaji Telefilms held its 32nd AGM on September 29, 2026, adopting FY26 financial statements
- Company clarified that delayed FY25 results were due to pending NCLT approval of Composite Scheme
- Board composition non-compliance from August to December 2025 was resolved with new director appointment
- Shareholders approved remuneration for MD Shobha Kapoor and JMD Ekta Kapoor for remaining two-year terms

*this image is generated using AI for illustrative purposes only.
Balaji Telefilms held its 32nd Annual General Meeting on September 29, 2026, via Video Conferencing. The company adopted audited financial statements for FY26 and addressed shareholders regarding recent regulatory non-compliances.
The meeting, which commenced at 3:30 pm and concluded at 4:50 pm, was attended by Chairman Jeetendra Kapoor and Managing Director Shobha Kapoor. Joint Managing Director Ekta Ravi Kapoor and several other directors were unable to attend. The proceedings included the adoption of standalone and consolidated financial statements for the year ended March 31, 2026.
Regulatory compliance updates
During the session, Company Secretary Tannu Sharma detailed specific instances of non-compliance with SEBI Listing Regulations that occurred during the preceding period. These issues were highlighted in the Secretarial Audit Report for FY26.
| Compliance Issue | Period of Non-Compliance | Reason Provided |
|---|---|---|
| Board Composition | Aug 31, 2025 to Dec 29, 2025 | Retirement of Independent Director upon completion of second tenure |
| Meeting Frequency | Exceeded 120-day gap limit | Pendency of Composite Scheme approval before NCLT |
| Financial Results Submission | Beyond 60-day stipulated timeline | Awaiting NCLT sanction of Composite Scheme for accurate presentation |
The company stated that the board composition default was rectified effective December 30, 2025, following the appointment of Pankaj Chaturvedi as an Independent Director. Sharma explained that the delay in submitting audited results for FY25 was due to the pending approval of the Composite Scheme of Arrangement by the National Company Law Tribunal (NCLT). The company awaited the NCLT order, received on June 10, 2025, to ensure accurate financial presentation from the appointed date of April 1, 2024.
Key resolutions passed
Shareholders approved several ordinary and special business items during the e-voting process, which remained open from September 25 to September 28, 2026.
- Adoption of Financial Statements: Approval of audited standalone and consolidated financial statements for FY26.
- Director Reappointment: Reappointment of Shobha Ravi Kapoor as Director, retiring by rotation.
- Continuation of Directorship: Approval for Priyanka Chaudhary to continue as Non-Executive, Non-Independent Director.
- Remuneration Approvals: Approval of remuneration for Shobha Ravi Kapoor (Managing Director) and Ekta Ravi Kapoor (Joint Managing Director) for their remaining two-year tenures starting November 10, 2026.
What the numbers show
The disclosure reveals a direct causal link between corporate restructuring delays and regulatory compliance lapses. The pendency of the Composite Scheme before the NCLT not only delayed the FY25 financial results beyond the 60-day SEBI mandate but also contributed to the gap exceeding 120 days between consecutive Board and Audit Committee meetings. This indicates that significant corporate actions, such as mergers or demergers, can have secondary effects on governance metrics if not managed with strict interim compliance protocols.
Historical Stock Returns for Balaji Telefilms
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.27% | -1.93% | -2.46% | +20.69% | -30.81% | +37.85% |
How will the recent regulatory non-compliances impact Balaji Telefilms' ESG ratings and institutional investor confidence in the upcoming quarters?
What specific interim governance protocols is the company implementing to prevent future compliance lapses during pending NCLT approvals for corporate restructuring?
Will the approval of the Composite Scheme of Arrangement lead to significant changes in the company's consolidated revenue structure or operational synergies in FY27?


































